Literature DB >> 30184517

Amino acid profile after oral nutritional supplementation in hemodialysis patients with protein-energy wasting.

Sylwia Małgorzewicz1, Grażyna Gałęzowska2, Monika Cieszyńska-Semenowicz2, Joanna Ratajczyk2, Lidia Wolska2, Przemysław Rutkowski3, Magdalena Jankowska3, Bolesław Rutkowski3, Alicja Dębska-Ślizień3.   

Abstract

OBJECTIVES: Protein-energy wasting (PEW) is highly prevalent in patients on hemodialysis (HD). Oral nutritional supplementation (ONS) is recommended for malnourished patients on HD. The aim of this study was to evaluate ONS on plasma amino acid in HD patients with PEW.
METHODS: Thirty-two HD patients with a mean age 59.1 ± 9.5 y with PEW were enrolled into the study. Patients were prescribed ONS (125 mL twice a day for 3 mo) together with dietary advice. The nutritional status was evaluated by means of body mass index, Subjective Global Assessment, and serum albumin and prealbumin levels. The percentages of body fat and lean body mass were measured by means of the near-infrared method. The lean body mass-to-body weight ratios were calculated. Tumor necrosis factor, interleukin-6 and high-sensitivity C-reactive protein, were measured by the enzyme-linked immunosorbent assay method. Serum concentrations of amino acids were measured by the high-performance liquid chromatography method.
RESULTS: After 3 mo of ONS, a significant increase of both serum prealbumin and albumin was observed. The concentration of most of the amino acids increased independently on inflammation.
CONCLUSIONS: Dietary advice, combined with ONS, is effective in HD patients with PEW. Both dietary advice and ONS are needed to be sure that patients consume an adequate daily amount of calories and protein.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amino acids; hemodialysis; malnutrition; oral supplements

Mesh:

Substances:

Year:  2018        PMID: 30184517     DOI: 10.1016/j.nut.2018.06.013

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  6 in total

1.  Effectiveness of renal-specific oral nutritional supplements compared with diet counseling in malnourished hemodialysis patients.

Authors:  Pokkrong Limwannata; Bancha Satirapoj; Samitti Chotsriluecha; Paramat Thimachai; Ouppatham Supasyndh
Journal:  Int Urol Nephrol       Date:  2021-01-16       Impact factor: 2.370

2.  Muscle Status Response to Oral Nutritional Supplementation in Hemodialysis Patients With Protein Energy Wasting: A Multi-Center Randomized, Open Label-Controlled Trial.

Authors:  Sharmela Sahathevan; Tilakavati Karupaiah; Ban-Hock Khor; Birinder Kaur Sadu Singh; Zulfitri Azuan Mat Daud; Enrico Fiaccadori; Alice Sabatino; Karuthan Chinna; Abdul Halim Abdul Gafor; Sunita Bavanandan; Ravindran Visvanathan; Rosnawati Yahya; Zaimi Wahab; Bak-Leong Goh; Zaki Morad; Boon Cheak Bee; Hin Seng Wong
Journal:  Front Nutr       Date:  2021-12-10

3.  Serum and Fecal Amino Acid Profiles in Cats with Chronic Kidney Disease.

Authors:  Stacie C Summers; Jessica Quimby; Amanda Blake; Deborah Keys; Joerg M Steiner; Jan Suchodolski
Journal:  Vet Sci       Date:  2022-02-17

4.  Intradialytic nutrition and quality of life in Chilean older patients in hemodialysis with protein-energy wasting.

Authors:  Mariana Ayala; Margarita Marchant; Cristina Hertz; Gloria Castillo
Journal:  Int Urol Nephrol       Date:  2021-12-03       Impact factor: 2.266

Review 5.  Intradialytic Nutrition and Hemodialysis Prescriptions: A Personalized Stepwise Approach.

Authors:  Giorgina Barbara Piccoli; Francoise Lippi; Antioco Fois; Lurlynis Gendrot; Louise Nielsen; Jerome Vigreux; Antoine Chatrenet; Claudia D'Alessandro; Gianfranca Cabiddu; Adamasco Cupisti
Journal:  Nutrients       Date:  2020-03-16       Impact factor: 5.717

Review 6.  Dietary protein interventions to improve nutritional status in end-stage renal disease patients undergoing hemodialysis.

Authors:  Floris K Hendriks; Jeroen P Kooman; Luc J C van Loon
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2021-01       Impact factor: 3.620

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.